Literature DB >> 12958313

hSef inhibits PC-12 cell differentiation by interfering with Ras-mitogen-activated protein kinase MAPK signaling.

Shiqin Xiong1, Qiuhui Zhao, Zhili Rong, Guanrong Huang, Yiling Huang, Peila Chen, Shuping Zhang, Li Liu, Zhijie Chang.   

Abstract

Growth factor signaling by receptor tyrosine kinases regulates several cell fates, such as proliferation and differentiation. Sef was genetically identified as a negative regulator of fibroblast growth factor (FGF) signaling. Using bioinformatic methods and rapid amplification of cDNA ends-PCR, we isolated both the mouse and the human Sef genes, which encoded the Sef protein and Sef-S isoform that was generated through alternative splicing. We provide evidence that the Sef gene products were located mainly on the cell membrane. Co-immunoprecipitation and immunostaining experiments indicate that hSef interacts with FGFR1 and FGFR2 but not FGFR3. Our results demonstrated that stably expressed hSef strongly inhibits FGF2- or nerve growth factor-induced PC-12 cell differentiation. The intracellular domain of hSef is necessary for the inhibitory effect on FGF2-induced PC-12 cell differentiation. Furthermore, our data suggested Sef exerted the negative effect on FGF2-induced PC-12 cell differentiation through the prevention of Ras-mitogen-activated protein kinase signaling, possibly functioning upstream of the Ras molecule. These findings suggest that Sef may play an important role in the regulation of PC-12 cell differentiation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12958313     DOI: 10.1074/jbc.M306936200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Control of MAP kinase signaling to the nucleus.

Authors:  Kunio Kondoh; Satoru Torii; Eisuke Nishida
Journal:  Chromosoma       Date:  2005-05-18       Impact factor: 4.316

2.  Ras, an actor on many stages: posttranslational modifications, localization, and site-specified events.

Authors:  Imanol Arozarena; Fernando Calvo; Piero Crespo
Journal:  Genes Cancer       Date:  2011-03

3.  Evolution of the IL17 receptor family in chordates: a new subfamily IL17REL.

Authors:  Baojun Wu; Meng Jin; Yi Zhang; Tiandi Wei; Zengliang Bai
Journal:  Immunogenetics       Date:  2011-07-06       Impact factor: 2.846

Review 4.  Characterization of Golgi scaffold proteins and their roles in compartmentalizing cell signaling.

Authors:  Wenna Peng; Qiang Lei; Zheng Jiang; Zhiping Hu
Journal:  J Mol Histol       Date:  2013-12-14       Impact factor: 2.611

5.  Sef is a negative regulator of fiber cell differentiation in the ocular lens.

Authors:  Peter Newitt; Jessica Boros; Bhavani P Madakashira; Michael L Robinson; Lixing W Reneker; John W McAvoy; Frank J Lovicu
Journal:  Differentiation       Date:  2010-06-09       Impact factor: 3.880

6.  IL-17RD (Sef or IL-17RLM) interacts with IL-17 receptor and mediates IL-17 signaling.

Authors:  Zhili Rong; Anan Wang; Zhiyong Li; Yongming Ren; Long Cheng; Yinghua Li; Yinyin Wang; Fangli Ren; Xiaoning Zhang; Jim Hu; Zhijie Chang
Journal:  Cell Res       Date:  2009-02       Impact factor: 25.617

Review 7.  Structure and signalling in the IL-17 receptor family.

Authors:  Sarah L Gaffen
Journal:  Nat Rev Immunol       Date:  2009-07-03       Impact factor: 53.106

Review 8.  Protein scaffolds in MAP kinase signalling.

Authors:  Matthew D Brown; David B Sacks
Journal:  Cell Signal       Date:  2008-12-03       Impact factor: 4.315

9.  hSef potentiates EGF-mediated MAPK signaling through affecting EGFR trafficking and degradation.

Authors:  Yongming Ren; Long Cheng; Zhili Rong; Zhiyong Li; Yinghua Li; Xinjun Zhang; Shiqin Xiong; Jim Hu; Xin-Yuan Fu; Zhijie Chang
Journal:  Cell Signal       Date:  2007-11-28       Impact factor: 4.315

10.  Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease.

Authors:  S Darby; T Murphy; H Thomas; C N Robson; H Y Leung; M E Mathers; V J Gnanapragasam
Journal:  Br J Cancer       Date:  2009-11-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.